The potential clinical significance of these findings is underscored by in vitro observations that HVEM‐expressing melanoma cell lines inhibit IFN‐γ production by Melan‐AMART‐1 Ag‐specific CD8+ T cell clones in a BTLA‐dependent manner.211. This evidence concerns the gene BTLA and melanoma.